We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Phytochemicals in Olive Oil Suppress Growth of Breast Cancer Cells

By LabMedica International staff writers
Posted on 30 Dec 2008
Spanish cancer researchers have found that the phytochemical components of extra-virgin olive oil repress the HER2/neu cancer oncogene and can effectively suppress growth of breast cancer cells overexpressing this gene.

Approximately 15-20% of breast cancers have an amplification of the HER2/neu gene or overexpression of its protein product. More...
Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. The acronym HER2/neu (also known as ErbB-2) stands for human epidermal growth factor receptor 2, which is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family.

Researchers in biomedical fields as diverse as cardiovascular diseases, autoimmune diseases, and cancer are seeking the molecular basis for the health benefits imparted by the "Mediterranean diet,” which is highly enriched with olive oil. In the current study, investigators from the Catalan Institute of Oncology (Spain) and the University of Granada (Spain) studied the effect of various components of extra-virgin olive oil (EVOO) on breast cancer. Since extra-virgin olive oil is obtained by pressing olives without the use of heat or chemical treatments, it contains phytochemicals that are otherwise lost in the refining process.

The investigators used solid phase extraction followed by semi-preparative high-performance liquid chromatography (HPLC) to isolate phenolic fractions from commercial EVOO. Analytic capillary electrophoresis coupled to mass spectrometry was performed to confirm the identity of the isolated fractions.

EVOO polyphenolic fractions were tested for their tumoricidal ability against HER2-negative and HER2-positive breast cancer cells growing in tissue culture using various chemical and immunological methods. Results presented in the December 18, 2008, online edition of the journal BMC Cancer revealed that all the major complex phenols present in extra-virgin olive oil drastically suppressed overexpression of the cancer gene HER2 in human breast cancer cells.

While this finding is of considerable interest in its own right, the investigators did caution that, "The active phytochemicals [i.e., lignans and secoiridoids] exhibited tumoricidal effects against cultured breast cancer cells at concentrations that are unlikely to be achieved in real life by consuming olive oil.” This fact notwithstanding, they went on to report that, "These findings, together with the fact that that humans have safely been ingesting significant amounts of lignans and secoiridoids as long as they have been consuming olives and extra-virgin oil, strongly suggest that these polyphenols might provide an excellent and safe platform for the design of new anti breast-cancer drugs.”

Related Links:
Catalan Institute of Oncology
University of Granada


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.